Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ellagic acid as a potent anticancer drug: A comprehensive review on in vitro, in vivo, in silico, and drug delivery studies
Arash Mohammadinejad, Taraneh Mohajeri, Ghazaleh Aleyaghoob, et al.
Biotechnology and Applied Biochemistry (2021) Vol. 69, Iss. 6, pp. 2323-2356
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Ellagic Acid and Its Anti-Aging Effects on Central Nervous System
Heyu Zhu, Yuanmei Yan, Yi Jiang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10937-10937
Open Access | Times Cited: 38
The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art
Guangying Lu, Xuezhen Wang, Ming Cheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115132-115132
Open Access | Times Cited: 31
A Drug Discovery Approach to a Reveal Novel Antioxidant Natural Source: The Case of Chestnut Burr Biomass
Alfonso Trezza, Michela Geminiani, Giuseppe Cutrera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2517-2517
Open Access | Times Cited: 9
A Review on Pharmacological Advancement of Ellagic Acid
Pougang Golmei, Sweta Kasna, Kumar Probin Roy, et al.
Journal of Pharmacology and Pharmacotherapeutics (2024) Vol. 15, Iss. 2, pp. 93-104
Open Access | Times Cited: 5
Identification of the Pharmacological Components and Its Targets of Sanghuang by Integration of Nontarget Metabolomics and Network Pharmacology Analysis
Hengqian Lu, Jingtao Zhang, Yongzhong Wang
Biomedical Chromatography (2025) Vol. 39, Iss. 2
Closed Access
Ellagic acid alleviates DSS–induced ulcerative colitis by inhibiting ROS/NLRP3 pathway activation and modulating gut microbiota in mice
Yanling Xiong, Zhentao Cheng, Yangzi Zhang, et al.
European Journal of Nutrition (2025) Vol. 64, Iss. 1
Closed Access
Synthesis and Characterization of Albumin Nanoparticles Loaded by Ellagic Acid and Chitosan and Investigation of Its Anticancer Activity Against Liver Cancer Cells
Anežka Hashim, Mohadese Alirezaei, Mozhgan Soltani, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Chemical profile and cytotoxic evaluation of aerial parts of Euphorbia tirucalli L. on gastric adenocarcinoma (AGS cells)
Larissa Silva de Souza, Cristina Luz Tosta, Jéssica Rodrigues Pereira de Oliveira Borlot, et al.
Natural Product Research (2023) Vol. 37, Iss. 24, pp. 4267-4273
Closed Access | Times Cited: 13
Investigation on the mechanisms by which the herbal remedies induce anti-prostate cancer activity: uncovering the most practical natural compound
Alireza Poustforoosh, Sanaz Faramarz, Manica Negahdaripour, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 7, pp. 3349-3362
Open Access | Times Cited: 13
Evaluation of the Potential Protective Effect of Ellagic Acid against Heavy Metal (Cadmium, Mercury, and Lead) Toxicity in SH-SY5Y Neuroblastoma Cells
Rosanna Mallamaci, Alexia Barbarossa, Alessia Carocci, et al.
Foods (2024) Vol. 13, Iss. 3, pp. 419-419
Open Access | Times Cited: 4
Cobalt oxide nanoparticles functionalized with glucose and conjugated to Ellagic acid (Co3O4@Glu-Ellagic acid NPs) induce apoptotic genes in HepG2, liver cancer cell line
Aida Mahmoudi, Vajiheh Zarrin Pour, Ali Salehzadeh
Gene Reports (2024) Vol. 35, pp. 101897-101897
Closed Access | Times Cited: 4
Improvement of obesity by Liupao tea is through the IRS-1/PI3K/AKT/GLUT4 signaling pathway according to network pharmacology and experimental verification
Zhimin Wu, Wenxin Yu, Wei‐Ju Ni, et al.
Phytomedicine (2022) Vol. 110, pp. 154633-154633
Closed Access | Times Cited: 21
Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway
Jiabin Wu, Ke Li, Muge Zhou, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100946-100946
Open Access | Times Cited: 3
Exploring the Anticancer Potential of Furanpydone A: A Computational Study on its Inhibition of MTHFD2 Across Diverse Cancer Cell Lines
Maram B. Alhawarri
Cell Biochemistry and Biophysics (2024)
Closed Access | Times Cited: 3
Ellagic Acid Prevents Particulate Matter-Induced Pulmonary Inflammation and Hyperactivity in Mice: A Pilot Study
Sun‐Young Jeong, Sungryong Bae, Eui‐Cheol Shin, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4523-4523
Open Access | Times Cited: 9
A network pharmacology approach to elucidate the anti-inflammatory effects of ellagic acid
Skyler H. Hoang, Hue Dao, Emerson My Lam
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 14, pp. 7409-7420
Open Access | Times Cited: 8
Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 501-574
Closed Access | Times Cited: 8
Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization
Qichao Hu, Wenwen Zhang, Feng Wei, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 1, pp. 280-304
Closed Access | Times Cited: 8
Mentha spicata assisted Ag–CuO nanocomposite enables anti-diabetic and vitamin-C sensing activities
Naiyer Shahzad, Ibrahim Abdel Aziz Ibrahim, Abdullah R. Alzahrani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105925-105925
Closed Access | Times Cited: 2
QbD decorated ellagic acid loaded polymeric nanoparticles: Factors influencing desolvation method and preliminary evaluations
Priya Patel, Ashish Thanki, Devesh U. Kapoor, et al.
Nano-Structures & Nano-Objects (2024) Vol. 40, pp. 101378-101378
Closed Access | Times Cited: 2
Protective activities of ellagic acid and urolithins against kidney toxicity of environmental pollutants: A review
Wylly Ramsés García‐Niño, Luz Ibarra-Lara, Mayra Yael Cuevas-Magaña, et al.
Environmental Toxicology and Pharmacology (2022) Vol. 95, pp. 103960-103960
Closed Access | Times Cited: 10
Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects
Nicolette Casarcia, Patrick Rogers, Emma Guld, et al.
British Journal of Pharmacology (2023)
Closed Access | Times Cited: 5
Research progress on the regulatory and pharmacological mechanism of chemical components of Dendrobium
Xin Wei, Dan Wang, Ziming Xu, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37541-e37541
Open Access | Times Cited: 1
Ellagic acid-protein nano-complex inhibits tumor growth by reducing the intratumor bacteria and inhibiting histamine production
Wu Bingbing, Chenlu Yao, Heng Wang, et al.
Biomaterials (2024) Vol. 317, pp. 123078-123078
Closed Access | Times Cited: 1
Characterizations of food-derived ellagic acid-Undaria pinnatifida polysaccharides solid dispersion and its benefits on solubility, dispersity and biotransformation of ellagic acid
Zhao‐Rong Li, Rui‐Bo Jia, Xueyuan Cai, et al.
Food Chemistry (2023) Vol. 413, pp. 135530-135530
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top